Identifying new prognostic markers and therapeutic targets to improve outcomes among people with lymphoma and leukemia

Our Lab

lab photo 2017

The Weinstock Laboratory uses a range of approaches at the intersection of genetics, DNA repair, and mouse modeling to address the ontogeny, pathogenesis, and therapeutic targeting of lymphoid neoplasms.